The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland

Thyroid

Volumn 22, Issue 9, 2012, Pages 884-889

  Nixon, Iain J ^a   Whitcher, Monica M ^a   Palmer, Frank L ^a   Tuttle, R Michael ^a   Shaha, Ashok R ^a   Shah, Jatin P ^a   Patel, Snehal G ^a   Ganly, Ian ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; DIFFERENTIATED THYROID CANCER; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM METASTASIS; NECK METASTASIS; OVERALL SURVIVAL; PHARYNX CANCER; PIRIFORM SINUS METASTASIS; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; SCHOOL CHILD; SKIN METASTASIS; THYROID SURGERY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CARCINOMA; CHILD; DISEASE PROGRESSION; FEMALE; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84865589843     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0535     Document Type: Article

References (23)

1. Dinneen SF, Valimaki MJ, Bergstralh EJ, Goellner JR, Gorman CA, Hay ID 1995 Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 80:2041-2045.
2. Lin JD, Huang MJ, Juang JH, Chao TC, Huang BY, Chen KW, Chen JY, Li KL, Chen JF, Ho YS 1999 Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. Thyroid 9:1227-1235.
3. Massin JP, Savoie JC, Garnier H, Guiraudon G, Leger FA, Bacourt F 1984 Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment. Cancer 53:982-992.
4. Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, Francese C, Fontaine F, Ricard M, Parmentier C 1996 Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 37:598-605.
5. Mihailovic J, Stefanovic L, Malesevic M 2007 Differentiated thyroid carcinoma with distant metastases: probability of survival and its predicting factors. Cancer Biother Radiopharm 22:250-255.
6. Casara D, Rubello D, Saladini G, Masarotto G, Favero A, Girelli ME, Busnardo B 1993 Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 34:1626-1631.
7. Haq M, Harmer C 2005 Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol 63:87-93.
8. Sugitani I, Fujimoto Y, Yamamoto N 2008 Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery 143:35-42.
9. Shaha AR, Shah JP, Loree TR 1997 Differentiated thyroid cancer presenting initially with distant metastasis. Am J Surg 174:474-476.
10. Lee J, Soh E-Y 2010 Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis. Ann Surg 251:114-119.
11. Showalter TN, Siegel BA, Moley JF, Baranski TJ, Grigsby PW 2008 Prognostic factors in patients with well-differentiated thyroid cancer presenting with pulmonary metastasis. Cancer Biother Radiopharm 23:655-660.
12. Shaha AR, Shah JP, Loree TR 1996 Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol 3:534-538.
13. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS 1993 Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1057; discussion 1057-1058.
14. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
15. Cady B, Rossi R 1988 An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104: 947-953.
16. Watkinson JC 2004 The British Thyroid Association guidelines for the management of thyroid cancer in adults. Nucl Med Commun 25:897-900.
17. Pacini F, Schlumberger M, Dralle H, Ilisea R, Smith Y, Viersinga V 2008 [European consensus on the management of patients with differentiated carcinoma of the thyroid from follicular epithelium]. Vestn Khir Im I I Grek 167: 52-56.
18. Riesco-Eizaguirre G, Gutierrez-Martinez P, Garcia-Cabezas MA, Nistal M, Santisteban P 2006 The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na + /I- targeting to the membrane. Endocr Relat Cancer 13:257-269.
19. Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, Caillou B, Ricard M, Lumbroso JD, De Vathaire F, Schlumberger M 2006 Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 91:2892-2899.
20. Shoup M 2003 Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg 197:191-197.
21. Mihailovic JM, Stefanovic LJ, Malesevic MD, Erak MD, Tesanovic DD 2009 Metastatic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases. Nucl Med Commun 30: 558-564.
22. Nguyen DX, Massague J 2007 Genetic determinants of cancer metastasis. Nat Rev Genet 8:341-352.
23. Nguyen DX, Bos PD, Massague J 2009 Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9:274-284.